Electromed, Inc.Electromed, Inc.Electromed, Inc.

Electromed, Inc.

No trades
No trades

SEC filings and other documents


Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
2026
Earnings, Q3 FY2026
May 12, 2026
Q3 delivered record revenue and profit growth, with strong execution and expanding market reach.
The 38th Annual Roth Conference
Mar 23, 2026
SmartVest's unique design and high-touch model drive profitable growth in a large, underserved market.
Earnings, Q2 FY2026
Feb 10, 2026
Record Q2 revenue and profit growth driven by home care strength and expanded market reach.
Earnings, Q1 FY2026
Nov 12, 2025
Q1 revenue up 15% to $16.9M, net income up 45%, and strong multi-channel growth.
2025
Earnings, Q4 FY2025
Annual
Aug 26, 2025
Record Q4 and annual revenue, strong margins, and double-digit growth across all key segments.
Investor presentation
Aug 26, 2025
Strong revenue growth and high margins driven by innovative airway clearance solutions.
Canaccord Genuity’s 45th Annual Growth Conference
Aug 12, 2025
SmartVest leverages clinical efficacy and direct distribution to drive growth in a large, expanding market.
Q2 Virtual Investor Summit Event
Jun 10, 2025
Strong growth, high margins, and unique direct-to-patient model drive expansion in airway care.
Earnings, Q3 FY2025
May 13, 2025
Achieved 10th consecutive quarter of double-digit revenue and net income growth.
Investor presentation
May 12, 2025
15th Annual LD Micro Invitational 2025
Apr 10, 2025
Innovative airway clearance devices drive growth in a large, underpenetrated market.
Sidoti Small-Cap Virtual Conference
Mar 20, 2025
Innovative respiratory care firm accelerates growth in a large, underdiagnosed market.
Oppenheimer 35th Annual Health Care MedTech and Services Conference
Mar 18, 2025
Direct-to-patient airway technology drives growth in a large, underdiagnosed market.
Earnings, Q2 FY2025
Feb 11, 2025
Record revenue and net income, strong segment growth, and robust cash position highlight Q2.
Investor presentation
Feb 11, 2025
Strong growth, high margins, and clinical impact drive leadership in airway clearance technology.
Earnings, Q1 FY2025
Nov 12, 2024
Q3 2024 revenue up 19% and net income surges, with $4.54M spent on share buybacks.
2024
Investor presentation
Nov 12, 2024
Earnings, Q4 FY2024
Annual
Aug 27, 2024
Investor presentation
Aug 26, 2024
Investor presentation
Aug 24, 2024
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024
Aug 14, 2024
Small-Cap Growth Virtual Investor Conference
Jun 12, 2024
Earnings, Q3 FY2024
May 7, 2024
Investor presentation
May 6, 2024